Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2012

01-02-2012 | Review

Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis

Authors: Ling Chen, Wen-Bin Zhou, Yi Zhao, Xiao-An Liu, Qiang Ding, Xiao-Ming Zha, Shui Wang

Published in: Breast Cancer Research and Treatment | Issue 1/2012

Login to get access

Abstract

Nipple discharge is a common complaint of patients with breast disease. The color of nipple discharge is always the first alarming symptom for patients. It is controversial whether the discharge color is an indicator of an underlying malignancy. The electronic database PubMed was searched for relevant articles. A meta-analysis about the association between the color of nipple discharge and breast cancer risk was conducted. Eight studies, including 3,110 patients, were eligible for this meta-analysis. Compared with patients in non-bloody nipple discharge group (179/1,478), patients in bloody nipple discharge group (404/1,632) had a markedly higher breast cancer risk (OR: 2.27, 95% CI: 1.32–3.89, P < 0.001 for heterogeneity). Compared with patients in clear/serous group (71/575), patients in bloody nipple discharge group (326/1,271) also had a higher risk (OR: 2.49, 95% CI: 1.25–4.93, P = 0.011 for heterogeneity). Furthermore, compared with patients in the colored group (55/448), patients in bloody nipple discharge group (296/1,124) (OR: 2.00, 95% CI: 0.74–5.45, P = 0.009 for heterogeneity) had no significant difference. Besides, there was no significant difference between patients in colored group (55/448) and clear/serous group (61/470) (OR: 1.35, 95% CI: 0.83–2.18, P = 0.707 for heterogeneity). Therefore, bloody nipple discharge could be a predictor of breast cancer risk among different colors of discharges. The symptom of bloody nipple discharge is helpful to the stratification of preoperative patients.
Literature
1.
go back to reference Gulay H, Bora S, Kilicturgay S, Hamaloglu E, Goksel HA (1994) Management of nipple discharge. J Am Coll Surg 178(5):471–474PubMed Gulay H, Bora S, Kilicturgay S, Hamaloglu E, Goksel HA (1994) Management of nipple discharge. J Am Coll Surg 178(5):471–474PubMed
2.
go back to reference Murphy IG, Dillon MF, Doherty AO, McDermott EW, Kelly G, O’Higgins N, Hill AD (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 96(6):457–463. doi:10.1002/jso.20801 PubMedCrossRef Murphy IG, Dillon MF, Doherty AO, McDermott EW, Kelly G, O’Higgins N, Hill AD (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 96(6):457–463. doi:10.​1002/​jso.​20801 PubMedCrossRef
3.
go back to reference Lang JE, Kuerer HM (2007) Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350–359PubMed Lang JE, Kuerer HM (2007) Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350–359PubMed
6.
go back to reference Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, Osborne M (2003) Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 10(2):113–116PubMedCrossRef Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, Osborne M (2003) Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 10(2):113–116PubMedCrossRef
7.
go back to reference Klein P, Glaser E, Grogan L, Keane M, Lipkowitz S, Soballe P, Brooks L, Jenkins J, Steinberg SM, DeMarini DM, Kirsch I (2001) Biomarker assays in nipple aspirate fluid. Breast J 7(6):378–387. doi:07601[pii] PubMedCrossRef Klein P, Glaser E, Grogan L, Keane M, Lipkowitz S, Soballe P, Brooks L, Jenkins J, Steinberg SM, DeMarini DM, Kirsch I (2001) Biomarker assays in nipple aspirate fluid. Breast J 7(6):378–387. doi:07601[pii] PubMedCrossRef
8.
go back to reference Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H (1997) Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76(4):494–501PubMedCrossRef Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H (1997) Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76(4):494–501PubMedCrossRef
10.
go back to reference Osako T, Iwase T, Takahashi K, Iijima K, Miyagi Y, Nishimura S, Tada K, Makita M, Akiyama F, Sakamoto G, Kasumi F (2007) Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years. Breast Cancer 14(3):255–259. doi:JST.JSTAGE/jbcs/14.255[pii] PubMedCrossRef Osako T, Iwase T, Takahashi K, Iijima K, Miyagi Y, Nishimura S, Tada K, Makita M, Akiyama F, Sakamoto G, Kasumi F (2007) Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years. Breast Cancer 14(3):255–259. doi:JST.​JSTAGE/​jbcs/​14.​255[pii] PubMedCrossRef
11.
go back to reference Liu GY, Lu JS, Shen KW, Wu J, Chen CM, Hu Z, Shen ZZ, Zhang TQ, Shao ZM (2008) Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Res Treat 108(2):271–277. doi:10.1007/s10549-007-9598-4 PubMedCrossRef Liu GY, Lu JS, Shen KW, Wu J, Chen CM, Hu Z, Shen ZZ, Zhang TQ, Shao ZM (2008) Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Res Treat 108(2):271–277. doi:10.​1007/​s10549-007-9598-4 PubMedCrossRef
15.
go back to reference Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S (2011) The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol. doi:10.1007/s00432-011-0979-z Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S (2011) The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol. doi:10.​1007/​s00432-011-0979-z
16.
go back to reference Zhou WB, Ding Q, Chen L, Liu XA, Wang S (2011) Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials. Breast Cancer Res Treat. doi:10.1007/s10549-011-1556-5 Zhou WB, Ding Q, Chen L, Liu XA, Wang S (2011) Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials. Breast Cancer Res Treat. doi:10.​1007/​s10549-011-1556-5
17.
go back to reference Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826PubMed Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–826PubMed
18.
go back to reference Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed
21.
go back to reference Montroni I, Santini D, Zucchini G, Fiacchi M, Zanotti S, Ugolini G, Manaresi A, Taffurelli M (2010) Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat 123(3):895–900. doi:10.1007/s10549-010-0815-1 PubMedCrossRef Montroni I, Santini D, Zucchini G, Fiacchi M, Zanotti S, Ugolini G, Manaresi A, Taffurelli M (2010) Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat 123(3):895–900. doi:10.​1007/​s10549-010-0815-1 PubMedCrossRef
28.
go back to reference Seltzer MH (2004) Breast complaints, biopsies, and cancer correlated with age in 10, 000 consecutive new surgical referrals. Breast J 10(2):111–117. doi:21284[pii] PubMedCrossRef Seltzer MH (2004) Breast complaints, biopsies, and cancer correlated with age in 10, 000 consecutive new surgical referrals. Breast J 10(2):111–117. doi:21284[pii] PubMedCrossRef
29.
go back to reference Leis HP Jr, Greene FL, Cammarata A, Hilfer SE (1988) Nipple discharge: surgical significance. South Med J 81(1):20–26PubMedCrossRef Leis HP Jr, Greene FL, Cammarata A, Hilfer SE (1988) Nipple discharge: surgical significance. South Med J 81(1):20–26PubMedCrossRef
31.
go back to reference Wong L, Chung YF, Wong CY (2000) Microdochectomy for single-duct nipple discharge. Ann Acad Med Singapore 29(2):198–200PubMed Wong L, Chung YF, Wong CY (2000) Microdochectomy for single-duct nipple discharge. Ann Acad Med Singapore 29(2):198–200PubMed
Metadata
Title
Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis
Authors
Ling Chen
Wen-Bin Zhou
Yi Zhao
Xiao-An Liu
Qiang Ding
Xiao-Ming Zha
Shui Wang
Publication date
01-02-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1787-5

Other articles of this Issue 1/2012

Breast Cancer Research and Treatment 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine